- Home
- RUMBW vs MDCXW Comparison
RUMBW vs MDCXW Comparison
Compare RUMBW & MDCXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUMBW
- MDCXW
- Stock Information
- Founded
- RUMBW 2013
- MDCXW N/A
- Country
- RUMBW United States
- MDCXW Canada
- Employees
- RUMBW 135
- MDCXW 12
- Industry
- RUMBW Computer Software: Prepackaged Software
- MDCXW
- Sector
- RUMBW Technology
- MDCXW
- Exchange
- RUMBW Nasdaq
- MDCXW Nasdaq
- Market Cap
- RUMBW N/A
- MDCXW N/A
- IPO Year
- RUMBW N/A
- MDCXW N/A
- Fundamental
- Price
- RUMBW $2.32
- MDCXW $0.90
- Analyst Decision
- RUMBW
- MDCXW
- Analyst Count
- RUMBW 0
- MDCXW 0
- Target Price
- RUMBW N/A
- MDCXW N/A
- AVG Volume (30 Days)
- RUMBW 39.1K
- MDCXW 6.0K
- Earning Date
- RUMBW 03-28-2025
- MDCXW 01-01-0001
- Dividend Yield
- RUMBW N/A
- MDCXW N/A
- EPS Growth
- RUMBW N/A
- MDCXW N/A
- EPS
- RUMBW N/A
- MDCXW N/A
- Revenue
- RUMBW $85,651,775.00
- MDCXW N/A
- Revenue This Year
- RUMBW N/A
- MDCXW N/A
- Revenue Next Year
- RUMBW N/A
- MDCXW N/A
- P/E Ratio
- RUMBW N/A
- MDCXW N/A
- Revenue Growth
- RUMBW 6.36
- MDCXW N/A
- 52 Week Low
- RUMBW $4.32
- MDCXW $1.12
- 52 Week High
- RUMBW $4.68
- MDCXW $1.34
- Technical
- Relative Strength Index (RSI)
- RUMBW 50.51
- MDCXW N/A
- Support Level
- RUMBW $2.40
- MDCXW N/A
- Resistance Level
- RUMBW $2.57
- MDCXW N/A
- Average True Range (ATR)
- RUMBW 0.17
- MDCXW 0.00
- MACD
- RUMBW 0.03
- MDCXW 0.00
- Stochastic Oscillator
- RUMBW 42.86
- MDCXW 0.00
About RUMBW Rumble Inc. Warrant
Rumble Inc is a free-to-use video-sharing platform where users can watch, share, like, comment, and upload their own videos. Users can subscribe to channels to stay in touch with recent creator content and access video-on-demand uploaded, and live content streamed, by creators. Geographically, it generates a majority of its revenue from the United States.
About MDCXW Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.